000710.SZ SHZ
Berry Genomics Co.,Ltd
1W: +14.2%
1M: +21.9%
3M: +38.5%
YTD: -14.4%
1Y: -26.5%
3Y: -1.8%
5Y: -64.1%
¥10.87 ($1.62)
+0.99 (+10.02%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$1.1B
-6.4% ▼
5Y CAGR: -7.8%
Gross Profit
$505M
+4.6% ▲
5Y CAGR: -12.6%
Operating Income
-$167M
+16.2% ▲
Net Income
-$192M
+55.0% ▲
EPS (Diluted)
$-0.54
+55.4% ▲
EBITDA
-$69M
+75.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $1.4B | $1.2B | $1.1B |
| YoY Growth | -4.8% | -7.7% | -3.8% | -15.8% | -6.4% |
| Cost of Revenue | $730M | $786M | $784M | $668M | $573M |
| Gross Profit | $811M | $636M | $584M | $483M | $505M |
| Gross Margin | 52.6% | 44.7% | 42.7% | 42.0% | 46.9% |
| R&D Expenses | $126M | $128M | $107M | $110M | $95M |
| SG&A Expenses | $326M | $357M | $327M | $167M | $131M |
| Operating Expenses | $554M | $620M | $608M | $934M | $672M |
| Operating Income | $245M | -$39M | -$23M | -$199M | -$167M |
| Operating Margin | 15.9% | -2.7% | -1.7% | -17.3% | -15.5% |
| Interest Expense | $16M | $22M | $18M | $17M | $10M |
| Income Before Tax | $245M | -$120M | -$283M | -$453M | -$171M |
| Tax Expense | $40M | -$11M | -$31M | -$28M | $17M |
| Net Income | $211M | -$110M | -$252M | -$427M | -$192M |
| Net Margin | 13.7% | -7.7% | -18.4% | -37.1% | -17.8% |
| EPS (Diluted) | $0.60 | $-0.31 | $-0.71 | $-1.21 | $-0.54 |
| EBITDA | $338M | $68M | -$62M | -$277M | -$69M |
| Shares Outstanding | 351M | 354M | 354M | 353M | 354M |